Literature DB >> 29247342

Effects of Banxia Xiexin Decoction () on Cisplatin-Induced Apoptosis of Human A549 Lung Cancer Cells.

Ha-Rim Kim1, Guem-San Lee2, Mi-Seong Kim1, Do-Gon Ryu3, Hong-Seob So1, Hyoung-Chul Moon4, Young-Rae Lee1,5, Sei-Hoon Yang6, Kang-Beom Kwon7,8.   

Abstract

OBJECTIVE: To examinie the synergistic effects of Banxia Xiexin Decoction (, Known as Banhasasim-tang in Korean) extract (BXDE) on cisplatin-induced cytotoxicity in the A549 human lung cancer cell lines.
METHODS: A549 cells were treated with varying concentrations (50-200 μg/mL) of cisplatin and BXDE alone or in combination for 96 h. We used 1-(4,5-dimethylthiazol-2-yl)-3,5-diphenylformazan assay and flow cytometry to analyze cell viability and apoptosis, respectively.
RESULTS: The exposure of cells to cisplatin and BXDE alone or in combination decreased cell viability dose- and time-dependently (P<0.05), which was found to be mediated by the apoptotic pathway as confirmed by the increase in the annexin V+/propidium iodide- stained cell population and a ladder pattern of discontinuous DNA fragments. Furthermore, the apoptosis was inhibited by the pan-caspase inhibitor, benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (z-VAD-FMK).
CONCLUSIONS: BXDE significantly potentiated apoptotic effects of cisplatin in A549 cells. Moreover, apoptosis induced by BXDE might be the pivotal mechanism mediating its chemopreventative action against cancer.

Entities:  

Keywords:  A549 cells; Banxia Xiexin Decoction; Chinese medicine; anticancer; apoptosis; cisplatin; synergism

Mesh:

Substances:

Year:  2018        PMID: 29247342     DOI: 10.1007/s11655-017-2922-x

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  23 in total

1.  Bax directly induces release of cytochrome c from isolated mitochondria.

Authors:  J M Jürgensmeier; Z Xie; Q Deveraux; L Ellerby; D Bredesen; J C Reed
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

2.  Aloe vera inhibits proliferation of human breast and cervical cancer cells and acts synergistically with cisplatin.

Authors:  Arif Hussain; Chhavi Sharma; Saniyah Khan; Kruti Shah; Shafiul Haque
Journal:  Asian Pac J Cancer Prev       Date:  2015

3.  Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology.

Authors:  M A Richardson; T Sanders; J L Palmer; A Greisinger; S E Singletary
Journal:  J Clin Oncol       Date:  2000-07       Impact factor: 44.544

4.  Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade.

Authors:  P Li; D Nijhawan; I Budihardjo; S M Srinivasula; M Ahmad; E S Alnemri; X Wang
Journal:  Cell       Date:  1997-11-14       Impact factor: 41.582

Review 5.  Mechanisms of caspase activation and inhibition during apoptosis.

Authors:  Yigong Shi
Journal:  Mol Cell       Date:  2002-03       Impact factor: 17.970

6.  [Effect of Japanese traditional medicine, TJ-41, on quality of life of patients with non-small cell lung cancer receiving outpatient chemotherapy].

Authors:  Yoshihisa Ishiura; Hiroki Yamamoto; Yasutaka Shiba; Yasushi Terasaki; Youichi Ishida; Fumiko Tanikawa; Hideko Hayase; Kazumi Maruyama; Chiemi Obata; Mika Ishikawa; Kazunori Hirokami; Kazuo Kasahara; Masaki Fujimura
Journal:  Gan To Kagaku Ryoho       Date:  2013-07

Review 7.  Cisplatin in cancer therapy: molecular mechanisms of action.

Authors:  Shaloam Dasari; Paul Bernard Tchounwou
Journal:  Eur J Pharmacol       Date:  2014-07-21       Impact factor: 4.432

Review 8.  The resurgence of platinum-based cancer chemotherapy.

Authors:  Lloyd Kelland
Journal:  Nat Rev Cancer       Date:  2007-07-12       Impact factor: 60.716

9.  Double-blind, placebo-controlled, randomized phase II study of TJ-14 (Hangeshashinto) for infusional fluorinated-pyrimidine-based colorectal cancer chemotherapy-induced oral mucositis.

Authors:  Chu Matsuda; Yoshinori Munemoto; Hideyuki Mishima; Naoki Nagata; Mitsuru Oshiro; Masato Kataoka; Junichi Sakamoto; Toru Aoyama; Satoshi Morita; Toru Kono
Journal:  Cancer Chemother Pharmacol       Date:  2015-05-17       Impact factor: 3.333

10.  Triptolide potentiates lung cancer cells to cisplatin-induced apoptosis by selectively inhibiting the NER activity.

Authors:  Gan Wang; Xing Wang; Xiaoxin Xu
Journal:  Biomark Res       Date:  2015-07-09
View more
  5 in total

Review 1.  Banxia Xiexin Decoction () Combined with Afatinib in Treatment of Advanced Gallbladder Cancer: Case Report and Literature Review.

Authors:  Li Su; Miao-Miao Wang; Meng-Ran Xu; Xiao Wang; Hong-Zhen Xia; Mei Zhang; Lei Zheng; Yao-Dong Zhu; Ming-Qi Wang; Ping Li
Journal:  Chin J Integr Med       Date:  2019-02-01       Impact factor: 1.978

2.  Acrid-release and bitter-downbearing therapy and banxia xiexin decoction regulate Wnt/β-catenin pathway, inhibit proliferation and invasion, and induce apoptosis in gastric cancer cells.

Authors:  Xiaofen Sun; Dewen Xue; Kanru Zhang; Fang Jiang; Duoqiao Li
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

Review 3.  Therapeutic Emergence of Rhein as a Potential Anticancer Drug: A Review of Its Molecular Targets and Anticancer Properties.

Authors:  Sahu Henamayee; Kishore Banik; Bethsebie Lalduhsaki Sailo; Bano Shabnam; Choudhary Harsha; Satti Srilakshmi; Naidu Vgm; Seung Ho Baek; Kwang Seok Ahn; Ajaikumar B Kunnumakkara
Journal:  Molecules       Date:  2020-05-12       Impact factor: 4.411

4.  Efficacy and safety of Banxia Xiexin Decoction as a complementary treatment for gastric cancer: A protocol for systematic review and meta-analysis.

Authors:  Meiqing Zhang; Wei Huang; Dongkai Yuan
Journal:  Medicine (Baltimore)       Date:  2021-04-30       Impact factor: 1.817

5.  Banxia xiexin decoction affects drug sensitivity in gastric cancer cells by regulating MGMT expression via IL‑6/JAK/STAT3‑mediated PD‑L1 activity.

Authors:  Xuan Feng; Feng Xue; Guihua He; Qing Ni; Suiping Huang
Journal:  Int J Mol Med       Date:  2021-07-19       Impact factor: 4.101

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.